drugset / Trial / NCT05241964

Platelet-rich Plasma(PRP) Injection in ED

NCT05241964

NaSingle-groupOpen-labelTreatment

Summary

RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. In theory, it is possibility of curing ED.

Timeline

Start
2021-03-22
Primary completion
2022-09-22
Completion
2022-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified

Indications